<i>ACTR10</i> Overexpression Facilitates the Progression and Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma
The upregulation of <i>ACTR10</i> accelerates HCC progression, promotes TKI resistance, and emerges as a prospective target for the treatment of HCC.
Authors
- Kai Qin
- Yongheng Chen
- Rong‐Rong He (ORCID: https://orcid.org/0000-0001-5505-5672)
- Zhimin Huang (ORCID: https://orcid.org/0000-0001-9230-6039)
- Yi Huang (ORCID: https://orcid.org/0000-0003-0456-3428)
- 邦彦 後藤
- Tong Wu (ORCID: https://orcid.org/0000-0002-6369-8253)
- Gang Chen (ORCID: https://orcid.org/0000-0002-3968-8530)
- Mei‐Hwan Wu (ORCID: https://orcid.org/0000-0002-7074-8087)
- Jie Luo (ORCID: https://orcid.org/0000-0002-5168-4719)
- Bin Yin (ORCID: https://orcid.org/0000-0003-3931-9660)
- Di Qin (ORCID: https://orcid.org/0000-0001-7887-6852)
- Jian Di Li
- Jian Jun Li
Institutions
- Guangxi University (CN)
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.14740/wjon1944
- Citations
- 1
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.33